In short
Localised colon cancer is often treated with surgery to remove the affected section of bowel. Rectal cancer more often needs radiotherapy or chemoradiotherapy before surgery. Higher-risk stage 2 and stage 3 disease may have chemotherapy such as FOLFOX after surgery. Some mismatch-repair deficient cancers respond to immunotherapy such as pembrolizumab. A stoma is not always needed.
Overall five-year survival for bowel cancer in England is about 60%. Stage at diagnosis drives that figure: over 90% at stage 1, around 10% at stage 4.
In low-income countries the same biology is often found later, and surgery plus chemotherapy are out of reach. World Aid Network funds that access through partner hospitals.
How is colon cancer treated differently from rectal cancer?
Colon cancer is usually operated on first. Rectal cancer sits lower in the pelvis, near the bladder, prostate or womb, so many people have radiotherapy or chemoradiotherapy before surgery to shrink the tumour.
A stoma (a bag on the abdomen) may be temporary while a join heals, or permanent if the bowel cannot be rejoined. Many people never need a permanent stoma.
What drugs are used for advanced bowel cancer?
Chemotherapy combinations such as FOLFOX, FOLFIRI or CAPOX are common. Targeted drugs such as bevacizumab (anti-VEGF) or cetuximab (anti-EGFR) are added for some people after tumour testing.
Immunotherapy, particularly pembrolizumab, helps the minority of bowel cancers that are mismatch-repair deficient (dMMR).
What will a donation for bowel cancer treatment provide?
In the UK these pathways are NHS care. World Aid Network does not replace the NHS. Overseas, a gift to the Cancer Emergency Appeal helps pay for tests, surgery or chemotherapy a family cannot afford, where partner oncologists can deliver them. The appeal funds all types of cancer.
What are the key takeaways?
- Surgery is the main treatment for early colon cancer; rectal cancer often needs pre-operative radiotherapy.
- Stage 1 five-year survival exceeds 90%; overall England survival is about 60%.
- A stoma is not automatic.
- We fund treatment access overseas, not UK clinics and not laboratory research.
Care like this is out of reach for millions
The diagnosis, screening and treatment described here are routine in the UK. In Pakistan, Indonesia and Malaysia, poverty puts them out of reach — so a treatable cancer too often becomes a fatal one. World Aid Network funds treatment through locally-licensed oncologists for patients who cannot pay.
Frequently asked questions
Will I need a stoma?
Not always. Many operations reconnect the bowel. A stoma may be temporary or permanent depending on location and the surgery needed. Rectal operations are more likely to involve a stoma than colon operations.
What is FOLFOX?
FOLFOX is a chemotherapy combination (folinic acid, fluorouracil and oxaliplatin) used after surgery for higher-risk disease and for some advanced cancers.
Does World Aid Network fund bowel cancer research?
No. Donations pay clinical bills for patients who cannot pay in Pakistan, Indonesia and Malaysia — not trials or labs.
This guide is general information, not medical advice. It was reviewed by the World Aid Network editorial team for accuracy against NHS and World Health Organization sources. Always speak to a GP or qualified clinician about your own health.